LINC01147: A Potential Drug Target and Biomarker (G101928791)

Target Name: LINC01147

NCBI ID: G101928791

LINC01147

Other Name(s): Long intergenic non-protein coding RNA 1147 | long intergenic non-protein coding RNA 1147

LINC01147: A Potential Drug Target and Biomarker

LINC01147 is a non-protein-coding RNA (ncRNA) molecule that has been identified by bioinformatics analysis as conserved across various organisms and has been annotated as a potential drug target and biomarker. LINC01147 is a small non-coding RNA molecule that is usually expressed in a highly variable manner in different cell types and tissues, but it is highly conserved across various species, making it a potential candidate for a drug target or biomarker.

Drug Target Potential

LINC01147 has been identified as a potential drug target due to its unique structure and the various cellular processes that it is involved in. LINC01147 is a small RNA molecule that is known to interact with various proteins, including transcription factors, RNA factors, and protein-protein interactions. It is also known to play a role in various cellular processes, including cell growth, apoptosis, and translation.

One of the key features of LINC01147 that makes it an attractive drug target is its ability to interact with multiple proteins at once. LINC01147 has been shown to interact with various transcription factors, including activator protein 1 (AP-1), which is a key transcription factor that is involved in cell growth and differentiation. LINC01147 has also been shown to interact with various RNA factors, including RNA-protein interaction factor 1 (RISF-1), which is a protein that is involved in regulating RNA stability and translation efficiency.

Another feature of LINC01147 that makes it an attractive drug target is its role in cell apoptosis. LINC01147 has been shown to be involved in the regulation of cell apoptosis, which is a natural process that helps the body eliminate damaged or dysfunctional cells. LINC01147 has been shown to interact with various proteins that are involved in cell apoptosis, including Bcl-2, which is a protein that is known to prevent cell apoptosis.

Biomarker Potential

In addition to its potential as a drug target, LINC01147 is also a potential biomarker for various diseases. LINC01147 has been shown to be involved in various cellular processes, including cell growth, apoptosis, and translation, which are important processes that are involved in the development and progression of various diseases.

One of the key potential applications of LINC01147 as a biomarker is its ability to be used as a diagnostic tool for various diseases, including cancer. LINC01147 has been shown to be involved in the regulation of cell cycle progression, which is a key aspect of cancer development. LINC01147 has also been shown to interact with various proteins that are involved in cell signaling, including the protein p53, which is a well-known protein that is involved in the regulation of apoptosis.

Another potential application of LINC01147 as a biomarker is its ability to be used as a therapeutic target for various diseases. LINC01147 has been shown to interact with various proteins that are involved in disease development and progression, including the protein TCF-1, which is a key transcription factor that is involved in the regulation of cell growth and differentiation. LINC01147 has also been shown to interact with various RNA factors, including RNA-protein interaction factor 2 (RISF-2), which is a protein that is involved in regulating RNA stability and translation efficiency.

Conclusion

In conclusion, LINC01147 is a small non-protein-coding RNA molecule that has been identified by bioinformatics analysis as conserved across various organisms and has the potential to be a drug target or biomarker. LINC01147 is known to interact with multiple proteins that are involved in

Protein Name: Long Intergenic Non-protein Coding RNA 1147

The "LINC01147 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01147 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets